patent

Genome Editing Patent belong to Broad Institute

The US patent office ruled Wednesday that hotly disputed patents on a revolutionary genome editing technology belong to the Broad Institute of Harvard and MIT, dealing a blow to the University of California’s effort to overturn those patents. In one sentence judgement by the Patent Trial and Appeal Board, three judges say key patent [...]

By |2017-09-07T18:45:46+05:30April 26th, 2017|Patent|0 Comments

Uber Launches New Patent purchase Program to help grow IP Industry

Uber has launched new patent purchase program called UP3, which will seek to expedite the process of purchasing patents with an open application. The idea is to get patent holder’s to propose a simple price they are willing to take for their patents, which Uber can take or leave, as a means to side [...]

By |2017-09-07T19:11:23+05:30April 13th, 2017|Patent|0 Comments

Hiring Freeze at USPTO concerns Industry groups

Members of United States innovators business community have delivered a letter to President Trump requesting that the US Patent and Trademark Office,be exempt from federal hiring freeze announced. The 5th april letter was signed by nearly two dozen organizations and other entities, including the Biotechnology Innovation Organisation, the innovation alliance, the alliance of US [...]

By |2017-09-07T19:11:53+05:30April 12th, 2017|Patent|0 Comments

New Apple Patent Hints AirPods Charging Case That Doubles As a Portable Charging Device

To begin with, the AirPods charging case doubles as a portable battery charging device which when placed on a flat surface turns into an Apple Watch charging pad. This is due to the incorporation of a “wireless power transmitting component”. The charging case will provide power for both the AirPods internally as well as a [...]

By |2017-09-07T19:18:33+05:30April 11th, 2017|IP Basics, Patent|0 Comments

Biogen Triumph in Techfidera dispute

Biogen has prevailed in a patent squabble with Denmark’s Forward Pharma over multiple sclerosis med Tecfidera—but the decision may not actually help the Big Biotech steer clear of generic rivals. The Patent Trial and Appeal Board (PTAB) ruled Friday that Forward could not declare patent infringement by Biogen. The verdict kept Biogen’s Tecfidera IP [...]

By |2017-09-07T19:47:24+05:30April 5th, 2017|Patent|0 Comments
Go to Top